DNA Comprehensive Genetic Risk Assessment Analysis
Comprehensive Genetic Risk Assessment
Real-Time Protection, Empowering a Healthier Future
Academic Hospital Genetic Technology Key Features of Genetic Risk Assessment
- Utilizing the Affymetrix GeneTitan automated multi-gene risk variant microarray platform, analyzing over one million genetic markers with enhanced reliability through population comparison data, while significantly reducing human error and contamination risks.
- All testing and risk assessments are conducted in Taiwan, with local laboratory assistants and certified medical technologists overseeing the process.
- Professional interpretation of genetic risks and variant findings is provided by physicians based on your test results.
- Non-invasive sample collection options: saliva, oral swab, or blood sample.
Risk Assessment Process
Oral Swab / Blood Collection
Extraction DNA
Genetic Risk Assessment Analysis
Assessment Report
Genetic Risk Assessment Categories
What Are the Benefits of Genetic Risk Assessment?
- For individuals with higher genetic risk, early awareness enables proactive health management and lifestyle adjustments.
- Identify potential inherited health risks within the family and support informed preventive planning.
- Identify genetic variations and risk markers to provide additional information that may support more accurate medical assessments.
Understanding Disease Origins and Who May Benefit
- Genetic Predisposition (Inherited Factors)
- Acquired Genetic Changes (Environmental Factors and Lifestyle Influences)
Who Should Consider Genetic Risk Assessment?
- Understand personal health risks in advance and use regular assessments to support preventive health management.
- Identify potential inherited risks and take early steps toward personalized health planning.
- Use genetic variant insights alongside professional evaluation to better understand health risks and support ongoing management.
Disease Assessment List
- 38 Cardiovascular Disease Risks
- 30 Cancer Risk Assessments
- 11 Neurodegenerative Disease Risks
- 5 Autoimmune Disease Risks
‣Ischemic Stroke Risk ‣Ventricular Fibrillation Risk ‣Myocardial Infarction Risk ‣Stenotic Disease Risk ‣Hypertension Risk ‣Hyperlipidemia Risk ‣Angina Risk ‣Atrial Fibrillation Risk ‣Low HDL Cholesterol Risk ‣Familial Heart Disease Risk ‣Dyslipidemia Risk ‣Familial Hypercholesterolemia Risk ‣Coronary Atherosclerosis Risk ‣Premature Coronary Artery Disease Risk ‣Brugada Syndrome Risk ‣Familial Hypertrophic Cardiomyopathy Risk ‣Left Ventricular Hypertrophy Risk ‣Left Ventricular Dilated Cardiomyopathy Risk ‣Marfan Syndrome Risk ‣Valvular Heart Disease Risk ‣Cardiac Conduction Block Risk ‣Aortic Aneurysm Risk ‣Aortic Dissection Risk ‣Atherosclerosis Risk ‣Ankyrin-B Deficiency Risk ‣Long QT Syndrome Risk ‣Short QT Syndrome Risk ‣Malignant Hyperthermia Risk ‣Pulmonary Hypertension Risk ‣Cardiac Baroreflex Dysfunction Risk ‣Hairy Cell Leukemia Risk ‣Ventricular Tachycardia Risk ‣Inherited Cholesterol Absorption Disorder Risk ‣Hyperthyroidism-Related Disease Risk ‣Red Blood Cell Membrane Disorder Risk ‣Congenital Adrenal Hyperplasia Risk ‣Catecholaminergic Polymorphic Ventricular ‣Tachycardia (CPVT) Risk ‣Congenital Hypertrophic Cardiomyopathy Risk ‣Obesity Risk ‣Multiple Myeloma Risk
Lung Cancer
Liver Cancer
Stomach Cancer
Breast Cancer
Oral Cancer
Esophageal Cancer
Pancreatic Cancer
Ovarian Cancer
Kidney Cancer
Nasopharyngeal Cancer
Laryngeal Cancer
Brain Tumor
Thyroid Cancer
Lymphoma
Cervical Cancer
Colorectal Cancer
Rectal Cancer
Endometrial Cancer
Bladder Cancer
Testicular Cancer
Prostate Cancer
Skin Cancer
Melanoma
HodgkinLymphoma
Non-dgkinLymphoma
ChronicMyeloid Leukemia (CML)
Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
‣Parkinson’s Disease Risk ‣Early-Onset Alzheimer’s Disease Risk ‣Late-Onset Alzheimer’s Disease Risk ‣Huntington’s Disease Risk ‣Multiple System Atrophy Risk ‣Motor Neuron Disease Risk ‣Leukoencephalopathy Risk ‣Progressive Supranuclear Palsy Risk ‣Hereditary Spinocerebellar Degeneration Risk ‣Amyotrophic Lateral Sclerosis (ALS) Risk ‣NOTCH3-Related Cerebral Autosomal ‣Dominant ‣Arteriopathy with Subcortical ‣Infarcts and Leukoencephalopathy (CADASIL) Risk
‣Systemic Lupus Erythematosus (SLE) Risk ‣Rheumatoid Arthritis Risk ‣Vitiligo Risk ‣Multiple Sclerosis Risk ‣Sjögren’s Syndrome Risk
Disclaimer
LUXE YOUNG Health Management Center is not a medical institution. This service provides health management and testing planning integration. Actual testing is performed by qualified partner medical institutions or certified laboratory facilities.

